2023 Editorial Calendar
Content themes:
- Bio/Pharma’s Top 10: Monthly tracker of the top 10 trends, deals, and developments impacting global bio/pharmaceutical industry performance and the global bio/pharmaceutical manufacturing value chain.
- The CDMO/CMO and Suppliers Report: The keys developments from CDMOs/CMOs and suppliers and trends shaping bio/pharmaceutical outsourcing and supply.
- Executive One-on-One: In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
- Manufacturing and Supply Lines: The latest from the bio/pharmaceutical manufacturing value chain, from raw materials to active pharmaceutical ingredients (small molecules and biologics) to drug products to packaging.
- Special Reports: Special coverage of DCAT webinars and education programs, including programs from DCAT Week as well as other industry-focused reports.
DCAT Value Chain Insights 2022 Editorial Calendar: January-December 2022
January 6 |
Bio/Pharma’s Top 10: An Industry Watchlist for 2023 The top 10 issues to be on the look for in 2023. |
January 13 |
CDMO/CMO and Suppliers Report: The Year Ahead in Pharma Outsourcing An outlook for bio/pharmaceutical outsourcing for 2023. |
January 20 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
January 27 |
Manufacturing and Supply Lines: The Impact Factors for 2023 Industry experts provide perspective on what they see as the key issues impacting bio/pharma manufacturing and supply in 2023. |
February 3 |
Bio/Pharma’s Top 10: Small Molecules & Biologics Top 10 trends in new drug approvals, including the mix between small molecules and biologics. |
February 10 |
The CDMO/CMO and Suppliers Report: API Sourcing Industry roundtable on key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates. |
February 17 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
February 24 |
Special Report: DCAT Week 2023 Preview Special preview of upcoming speakers and education programs at DCAT Week 2022 (March 20 to March 23, 2023). |
March 3 |
Special Report: DCAT Week 2023 Preview Special preview of upcoming speakers and education programs at DCAT Week 2022 (March 20 to March 23, 2023). |
March 10 |
The CDMO/CMO and Suppliers Report: Cell & Gene Therapies Update of key expansions from CDMOs/CMOs for manufacturing of cell and gene therapies. |
March 17 |
No issue DCAT Week 2023 (March 20 to March 23, 2023). |
March 24 |
No issue DCAT Week 2023 (March 20 to March 23, 2023). |
March 31 |
Special Report: DCAT Week 2023 in Review Detailed roundup from the DCAT Member Company Announcement Forum and the DCAT Research & Benchmarking Study as presented at DCAT Week 2023. |
April 7 |
Special Report: DCAT Week 2023 in Review Roundup from the education programs at DCAT Week 2023, including a bio/pharmaceutical industry outlook. |
April 14 |
The CDMO/CMO and Suppliers Report: Parenteral Drugs Update of key expansions from CDMOs/CMOs in parenteral drug development and manufacturing. |
April 21 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
April 28 |
Manufacturing and Supply Lines: Small-Molecule APIs Market overview for small-molecule active pharmaceutical ingredients (APIs) and supply–demand fundamentals. |
May 5 |
Bio/Pharma’s Top 10: Blockbuster Watchlist A look at the top 10 drugs slated for launch in 2023 with blockbuster potential over the next five years. |
May 12 |
The CDMO/CMO and Suppliers Report: Biomanufacturing Expansions and technology updates in upstream and downstream bioprocessing. |
May 19 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
May 26 |
No issue |
June 2 |
Bio/Pharma’s Top 10: Top Deals Thus Far in 2023 Analysis of top 10 mergers and acquisitions and partnering deals among bio/pharma companies thus far in 2023. |
June 9 |
The CDMO/CMO and Suppliers Report: What’s Trending in Pharma Outsourcing The key trends and developments in the CDMO/CMO sector. |
June 16 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
June 23 |
Manufacturing and Supply Lines: Inside Big Pharma’s Manufacturing Networks The latest manufacturing expansion activity among the bio/pharmaceutical majors. |
June 30 |
Special Report: Generic Drugs Market outlook and analysis of key developments in the generic-drug industry. |
July 7 |
No issue |
July 14 |
The CDMO/CMO and Suppliers Report High-Potency APIs Update on expansions by CDMOs/CMOs for high-potency active pharmaceutical ingredients (HPAPI) manufacturing and related trends. |
July 21 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
July 28 |
Manufacturing and Supply Lines: Injectable Drugs Industry experts provide insight on key trends and technological developments for injectable drugs, including drug-device technology. |
August 4 |
Bio/Pharma’s Top 10: Emerging Pharma Top 10 Emerging Pharma companies gaining interest from investors and larger pharma companies in partnering deals. |
August 11 |
The CDMO/CMO and Suppliers Report: Packaging Industry overview of key trends and developments in primary and secondary packaging. |
August 18 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
August 25 |
No issue |
September 1 |
Bio/Pharma’s Top 10: Biologics The top 10-selling biologics and pipeline contenders. |
September 8 |
The CDMO/CMO and Suppliers Report: Formulation Development and Drug Products Latest market and technological advances for solid-dosage and parenteral drugs. |
September 15 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
September 22 |
Manufacturing and Supply Lines: Small-Molecule APIs Analysis of key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates. |
September 29 |
Special Report: India Analysis of import and export data for active pharmaceutical ingredients and drug products in India. |
October 6 |
Bio/Pharma’s Top 10: Small Molecules The top 10-selling biologics and pipeline contenders. |
October 13 |
The CDMO/CMO and Suppliers Report: Biomanufacturing A roundup of key expansions by CDMOs/CMOs in biomanufacturing. |
October 20 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
October 27 |
Manufacturing and Supply Lines: Continuous Manufacturing Update of key projects, investments, and advances in continuous manufacturing for both active pharmaceutical ingredients and drug products. |
November 3 |
Bio/Pharma’s Top 10: The Pipeline Contenders Top 10 late-stage drug candidates with strong market potential. |
November 10 |
The CDMO/CMO and Suppliers Report: High-Potency Drug Products A roundup of expansions of CDMOs/CMOs in high-potency drug-product manufacturing. |
November 17 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
November 24 |
No issue Thanksgiving Holiday. |
December 1 |
Bio/Pharma’s Top 10: The Year in Review A look at the top 10 developments in the bio/pharma industry in 2023. |
December 8 |
The CDMO/CMO and Suppliers Report: The Movers and Shakers of 2023 A look at the top expansions and mergers/acquisitions from CDMOs/CMOs in 2023. |
December 15 |
Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations. |
There are no issues December 22 and December 29.